Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

65 trials with published results (13%)

Research Maturity

282 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.6%

33 terminated out of 499 trials

Success Rate

89.5%

+2.9% vs benchmark

Late-Stage Pipeline

13%

64 trials in Phase 3/4

Results Transparency

23%

65 of 282 completed with results

Key Signals

65 with results90% success33 terminated

Data Visualizations

Phase Distribution

406Total
Not Applicable (256)
Early P 1 (4)
P 1 (33)
P 2 (49)
P 3 (37)
P 4 (27)

Trial Status

Completed282
Unknown73
Recruiting53
Terminated33
Not Yet Recruiting22
Active Not Recruiting14

Trial Success Rate

89.5%

Benchmark: 86.6%

Based on 282 completed trials

Clinical Trials (499)

Showing 20 of 20 trials
NCT06412315Not ApplicableRecruiting

7T Amygdala and Citalopram Study

NCT06206226Not ApplicableRecruiting

The Oh Happy Day Class - Digital Connections (OHDC-DC): A Pilot Study

NCT06440460Active Not Recruiting

Intergenerational Study of War-Affected Youth

NCT07841483Not ApplicableActive Not RecruitingPrimary

AI Mental Health Tool vs. Psychoeducation Control

NCT06934135Not ApplicableCompleted

Near-infrared Transcranial Laser Therapy in Subjects With Major Depressive Disorder

NCT05631184Not ApplicableCompleted

Self-administered Acupressure for Depression

NCT06668701CompletedPrimary

Evaluation of the Naturalistic User Experience of the Website "Ich Bin Alles"

NCT06038721Not ApplicableRecruiting

Unified Protocol: Community Connections

NCT07819448Not ApplicableRecruitingPrimary

Aerobic Exercise as an Adjunct Therapy for Depression

NCT05641623Phase 2Recruiting

OSU6162 as add-on in SSRI/SNRI-resistant Depression

NCT07818057CompletedPrimary

Validity of the 3-item Patient Health Questionnaire (PHQ-3) for Identifying Moderate-to-Severe Depressive Symptoms Among Elderly Perioperative Patients: A Secondary Analysis of a National Prospective Cohort

NCT06511908Phase 2Recruiting

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

NCT06901739Not ApplicableRecruiting

Therapeutic Potential of a Synbiotic to Improve Mental Health in Subjects With Obesity.

NCT07807072Not ApplicableCompletedPrimary

iACT & iTBS for Sleep Quality in Depressed Adolescents

NCT06080646Completed

Reward Processing and Depressive Subtypes: Identifying Neural Biotypes

NCT06143293Not ApplicableActive Not Recruiting

RESEARCH EVALUATING VAGAL EXCITATION AND ANATOMICAL LINKS

NCT07800663Not ApplicableCompletedPrimary

Sensory Hyperstimulation for Treating Depression

NCT06170801Not ApplicableCompletedPrimary

Group Intervention for Interpersonal Skills

NCT07058532Not ApplicableWithdrawn

Therapeutic Writing for Adults Suffering From Chronic Pain and Comorbid Mental Health Disorders

NCT05127837Not ApplicableCompleted

CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies

Scroll to load more

Research Network

Activity Timeline